Zdrowie i gospodarka · 25/11/2025
FDA Proposes Changes to Nucleic Acid-Based Test Systems for Oncology Therapeutic Products
The FDA is proposing to reclassify certain nucleic acid-based test systems for use with approved oncology therapeutic products, shifting them from premarket approval to special controls, and introducing new device classification regulations to ensure safety and effectiveness.